← Back to headlines
Allogene Therapeutics Receives FDA Fast Track and RMAT Designations for Cell Therapy
Allogene Therapeutics saw its stock rise after the FDA granted Fast Track and Regenerative Medicine Advanced Therapy (RMAT) designations for its cell therapy.
29 Jul, 17:47 — 29 Jul, 17:47
Sources
Showing 1 of 1 sources
